Inventor · disambiguated record
Ellen K. Kick
Also filed as: KICK ELLEN K
18 granted patents·4 pending applications·99 citations·filing 1998–2021
91Inventor score
Files withBRISTOL MYERS SQUIBB CO18BUSCH BRETT B1EXELIXIS PATENT CO LLC1KICK ELLEN K1UNIV CALIFORNIA1
Top patents by PatentIndex Score
22 records- 0193US7790745B2Tetrahydroisoquinoline LXR ModulatorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Sep 7, 2010·41 cites·20 claims
- 0290US7741317B2LXR modulatorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jun 22, 2010·13 cites·17 claims
- 0388US10676431B2Phenylpyrrolidinone formyl peptide 2 receptor agonistsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jun 9, 2020·6 cites·53 claims
- 0485US11117861B2Phenylpyrrolidinone formyl peptide 2 receptor agonistsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Sep 14, 2021·2 cites·15 claims
- 0584US11708327B2Phenylpyrrolidinone formyl peptide 2 receptor agonistsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Jul 25, 2023·1 cites·16 claims
- 0682US8618154B2LXR modulatorsBUSCH BRETT B·Filed 2010·Granted Dec 31, 2013·6 cites·30 claims
- 0772US11008301B2Piperidinone formyl peptide 2 receptor agonistsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted May 18, 2021·1 cites·9 claims
- 0870US9920075B2Triazolopyridine and triazolopyrimidine inhibitors of myeloperoxidaseBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Mar 20, 2018·1 cites·9 claims
- 0966US10407422B2Triazolopyridine inhibitors of myeloperoxidaseBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Sep 10, 2019·1 cites·11 claims
- 1064US6150416ANanomolar, non-peptide inhibitors of cathepsin DUNIV CALIFORNIA·Filed 1998·Granted Nov 21, 2000·26 cites·35 claims
- 1160US8901106B2Imidazole prodrug LXR modulatorsKICK ELLEN K·Filed 2012·Granted Dec 2, 2014·1 cites·14 claims
- 1258US2014163081A1Lxr modulatorsEXELIXIS PATENT CO LLC·Filed 2013·Application pending·0 cites
- 1350US2022298186A1Biaryl dialkyl phosphine oxide fpr2 agonistsBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 1450US2015299136A1Lxr modulatorsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 1549US2023348426A1Oxopyrrolidine fpr2 agonistsBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 1648US11180490B2Cyclopropyl urea formyl peptide 2 receptor and formyl peptide 1 receptor agonistsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Nov 23, 2021·0 cites·12 claims
- 1745US7569725B2Anthranilic acid derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase 3BRISTOL MYERS SQUIBB CO·Filed 2005·Granted Aug 4, 2009·0 cites·9 claims
- 1842US9834542B2LXR modulatorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Dec 5, 2017·0 cites·19 claims
- 1938US11008317B2Triazolopyridine inhibitors of myeloperoxidase and/or EPXBRISTOL MYERS SQUIBB CO·Filed 2017·Granted May 18, 2021·0 cites·5 claims
- 2038US10577383B2Macrocyclic inhibitors of myeloperoxidaseBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Mar 3, 2020·0 cites·5 claims
- 2137US10316035B2Triazolopyridine inhibitors of myeloperoxidaseBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jun 11, 2019·0 cites·9 claims
- 2237US9751869B2LXR modulatorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Sep 5, 2017·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Ellen K. Kick files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →